300 results
8-K
EX-99.1
CRDF
Cardiff Oncology Inc
2 May 24
Cardiff Oncology Reports First Quarter 2024 Results and Provides Business Update
4:10pm
-Looking Statements
Certain statements in this press release are forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995 … and litigation; dependence upon third parties; and risks related to failure to obtain FDA clearances or approvals and noncompliance with FDA regulations
8-K
EX-99.2
CRDF
Cardiff Oncology Inc
29 Feb 24
Cardiff Oncology Reports Fourth Quarter and Full Year 2023 Results and Provides Business Update
4:08pm
Securities Litigation Reform Act of 1995. These statements may be identified using words such as "anticipate," "believe," "forecast," "estimated … and litigation; dependence upon third parties; and risks related to failure to obtain FDA clearances or approvals and noncompliance with FDA regulations
8-K
EX-99.3
CRDF
Cardiff Oncology Inc
29 Feb 24
Cardiff Oncology Reports Fourth Quarter and Full Year 2023 Results and Provides Business Update
4:08pm
.
Forward-Looking Statements
Certain statements in this press release are forward-looking within the meaning of the Private Securities Litigation Reform Act … on key personnel; limited experience in marketing and sales; substantial competition; uncertainties of patent protection and litigation; dependence upon
8-K
EX-99.4
CRDF
Cardiff Oncology Inc
29 Feb 24
Cardiff Oncology Reports Fourth Quarter and Full Year 2023 Results and Provides Business Update
4:08pm
competition; uncertainties of patent protection and litigation; dependence upon third parties; and risks related to failure to obtain FDA clearances
8-K
EX-99.1
p72av
29 Feb 24
Cardiff Oncology Reports Fourth Quarter and Full Year 2023 Results and Provides Business Update
4:08pm
8-K
EX-99.1
227c559tc4cfg
2 Nov 23
Cardiff Oncology Reports Third Quarter 2023 Results and Provides Business Update
4:06pm
8-K
EX-99.2
u36 i3r6fqir16wk
2 Nov 23
Cardiff Oncology Reports Third Quarter 2023 Results and Provides Business Update
4:06pm
8-K
EX-99.2
xt9i4vsg tm
26 Sep 23
Pancreatic Cancer and Small Cell Lung Cancer Program Updates
4:07pm
8-K
EX-99.1
769xsjt
9 Aug 23
Cardiff Oncology Reports Second Quarter 2023 Results and Provides Business Update
4:06pm
8-K
EX-99.2
vy6o k31u6
7 Aug 23
AU GU ST 7 , 2 0 2 3 mCRC Program Update and Clinical Development Plan
4:42pm
8-K
EX-99.1
kzrm voqolpg
4 May 23
Cardiff Oncology Reports First-Quarter 2023 Results and Provides Business Update
4:01pm
8-K
EX-99.1
pc50t
3 Nov 22
Cardiff Oncology Reports Third Quarter 2022 Results and Provides Business Updates
4:14pm
8-K
EX-99.3
9svvrwmgnze90e1zv0
12 Sep 22
Regulation FD Disclosure
4:09pm